Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Acquisitions & Divestments: 2019-2024

Historic Change in Acquisitions & Divestments for Krystal Biotech (KRYS) over the last 6 years, with Dec 2024 value amounting to $298.5 million.

  • Krystal Biotech's Change in Acquisitions & Divestments rose 20.87% to $95.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $350.4 million, marking a year-over-year increase of 12.07%. This contributed to the annual value of $298.5 million for FY2024, which is 40.67% down from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Change in Acquisitions & Divestments is $298.5 million, which was down 40.67% from $503.2 million recorded in FY2023.
  • In the past 5 years, Krystal Biotech's Change in Acquisitions & Divestments registered a high of $503.2 million during FY2023, and its lowest value of $6.9 million during FY2020.
  • For the 3-year period, Krystal Biotech's Change in Acquisitions & Divestments averaged around $353.1 million, with its median value being $298.5 million (2024).
  • Per our database at Business Quant, Krystal Biotech's Change in Acquisitions & Divestments skyrocketed by 704.54% in 2022 and then crashed by 40.67% in 2024.
  • Over the past 5 years, Krystal Biotech's Change in Acquisitions & Divestments (Yearly) stood at $6.9 million in 2020, then surged by 366.40% to $32.0 million in 2021, then soared by 704.54% to $257.7 million in 2022, then spiked by 95.29% to $503.2 million in 2023, then tumbled by 40.67% to $298.5 million in 2024.